[Retracted] ZFP36 Inhibits Tumor Progression of Human Prostate Cancer by Targeting CDK6 and Oxidative Stress

Table 3

Correlation between clinicopathological characteristics and biochemical recurrence-free survival of PCa patients.

Parameters	Univariate analysis		Multivariate analysis
	HR (95% CI)		HR (95% CI)
ZFP36	0.764 (0.630-0.926)	0.006	0.767 (0.625-0.942)	0.012
Age	1.019 (0.979-1.061)	0.351	1.012 (0.969-1.057)	0.580
Gleason score	2.074 (1.583-2.717)	<0.001	1.842 (1.320-2.572)	<0.001
Pathological stage (T2 vs. T3)	5.110 (2.189-11.928)	<0.001	2.145 (0.839-5.481)	0.111
Clinical stage (<T2A vs. ≥T2A)	3.378 (1.688-6.759)	0.001	2.284 (1.112-4.692)	0.025
Surgical margin (+ vs −)	1.856 (1.087-3.166)	0.023	1.044 (0.554-1.970)	0.893

Note: HR: hazard ratio; CI: confidence interval.